Nirsevimab Reduces Medically Attended RSV-Associated Lower Respiratory Tract Infection and Hospitalisations in Healthy Pre-Term Infants

• 2022

  Log in to bookmark this resource.

  Log in
• Sarah Murphy
PMID: 33597216DOI: https://dx.doi.org/10.1136/archdischild-2020-321141

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This article comments on a study on how nirsevimab helps reduce RSV-related lung infections and hospital visits in healthy pre-term infants. It highlights the benefits of using a single dose of nirsevimab to prevent these infections. The article is part of ongoing research to find better ways to protect young children from respiratory illnesses caused by RSV, aiming for safer health outcomes for vulnerable infants.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Collection: Nirsevimab Library

Keywords: Antibodies, Monoclonal; Hospitalization; Infant; Neonatology; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Therapeutics; Antibodies, Monoclonal, Humanized

Institutions: University College Cork

---

More like this

Strategies for Improving Vaccine Communication and Uptake 2024 · American Academy of Pediatrics (AAP), University of Colorado, Seattle Children's Hospital, New York Medical College Nirsevimab Reduces Medically Attended RSV-Associated Lower Respiratory Trract Infection and Hospitalisations in Healthy Pre-Term Infants 2022 · University College Cork Diagnosis, Treatment, and Prevention of Monkeypox in Children: An Experts’ Consensus Statement 2023 · Capital Medical University, Shenzhen Children's Hospital, Chinese Center for Disease Control and Prevention, Chinese Academy of Medical Science & Peking Union Medical College, Beijing Children's Hospital

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---